Dorothy Engelking

Dorothy Engelking

No open positions remaining
65 year
Health Technology
Commercial Services
Consumer Services

Profile

Dorothy Engelking formerly worked at Actavis, Inc., as Vice President-Regulatory Affairs from 1999 to 2006, Kendle International LLC, as Vice President-Global Regulatory Affairs from 2008 to 2009, Adamas Pharmaceuticals LLC, as VP-Regulatory Affairs & Quality Assurance from 2019 to 2021, Xanodyne Pharmaceuticals, Inc., as Senior Vice President-Regulatory Affairs from 2006 to 2008, Neos Therapeutics, Inc., as Vice President-Regulatory Affairs, and DURECT Corp., as Vice President-Regulatory Affairs from 2022 to 2025.
Ms. Engelking received her undergraduate degree and graduate degree from South Dakota School of Mines & Technology.

Former positions of Dorothy Engelking

CompaniesPositionEnd
DURECT General Counsel 28/02/2025
ADAMAS PHARMACEUTICALS, INC. General Counsel 30/11/2021
General Counsel 30/06/2009
General Counsel 30/06/2008
General Counsel 28/02/2006
See the detail of Dorothy Engelking's experience

Training of Dorothy Engelking

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

57

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Dorothy Engelking